About: novel tobacco products

BAT: Need for a ‘consistent’ science-based view on e-cigarettes

The public health community needs to adopt a consistent science-based view on new generation tobacco products in order to properly inform regulators around the world and thereby shape a stable framework, James Murphy, the head of Reduced Risk Substantiation at British American Tobacco (BAT) told EURACTIV.com in an interview.

Commission remains ‘very cautious’ toward novel tobacco products, EU official says

The European Commission remains “cautious” toward novel tobacco products and has to continue collecting evidence on their impact on public health, according to a European Commission official. EURACTIV.com reports from Austria.